A phase 2 study of belinostat (PXD101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: a California Cancer Consortium Study (Q34084575)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 2 study of belinostat (PXD101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: a California Cancer Consortium Study |
scientific article |
Statements
1 reference
A phase 2 study of belinostat (PXD101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: a California Cancer Consortium Study (English)
1 reference
Mark H Kirschbaum
1 reference
Kenneth A Foon
1 reference
Paul Frankel
1 reference
Christopher Ruel
1 reference
Bernadette Pulone
1 reference
Joseph M Tuscano
1 reference
Edward M Newman
1 reference
24 February 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference